Caschera Filippo, Karim Ashty S, Gazzola Gianluca, d'Aquino Anne E, Packard Norman H, Jewett Michael C
Rutgers Center for Operations Research , Rutgers Business School , 100 Rockafeller Road , Piscataway , New Jersey 08854 , United States.
ProtoLife, Inc. , 57 Post Street Suite 908 , San Francisco , California 94104 , United States.
ACS Synth Biol. 2018 Dec 21;7(12):2841-2853. doi: 10.1021/acssynbio.8b00276. Epub 2018 Nov 19.
Building variant ribosomes offers opportunities to reveal fundamental principles underlying ribosome biogenesis and to make ribosomes with altered properties. However, cell viability limits mutations that can be made to the ribosome. To address this limitation, the in vitro integrated synthesis, assembly and translation (iSAT) method for ribosome construction from the bottom up was recently developed. Unfortunately, iSAT is complex, costly, and laborious to researchers, partially due to the high cost of reaction buffer containing over 20 components. In this study, we develop iSAT in Escherichia coli BL21Rosetta2 cell lysates, a commonly used bacterial strain, with a cost-effective poly sugar and nucleotide monophosphate-based metabolic scheme. We achieved a 10-fold increase in protein yield over our base case with an evolutionary design of experiments approach, screening 490 reaction conditions to optimize the reaction buffer. The computationally guided, cell-free, high-throughput technology presented here augments the way we approach multicomponent synthetic biology projects and efforts to repurpose ribosomes.
构建变异核糖体为揭示核糖体生物发生的基本原理以及制造具有改变特性的核糖体提供了机会。然而,细胞活力限制了可对核糖体进行的突变。为解决这一限制,最近开发了一种自下而上构建核糖体的体外整合合成、组装和翻译(iSAT)方法。不幸的是,iSAT对研究人员来说复杂、昂贵且费力,部分原因是含有20多种成分的反应缓冲液成本高昂。在本研究中,我们在常用的细菌菌株大肠杆菌BL21Rosetta2细胞裂解物中开发了iSAT,采用了一种具有成本效益的基于多糖和单磷酸核苷酸的代谢方案。通过实验的进化设计方法,我们筛选了490种反应条件以优化反应缓冲液,蛋白质产量比基础情况提高了10倍。这里介绍的计算指导的无细胞高通量技术改进了我们处理多组分合成生物学项目以及改造核糖体的方式。